Free USCA Notice of Docketing ROA - District Court of Delaware - Delaware


File Size: 64.8 kB
Pages: 2
Date: April 29, 2008
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 445 Words, 2,836 Characters
Page Size: 614 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/36007/189.pdf

Download USCA Notice of Docketing ROA - District Court of Delaware ( 64.8 kB)


Preview USCA Notice of Docketing ROA - District Court of Delaware
Case 1 :06-cv-00033-SLR Document 189 Filed O4/28/2008 Page (yy f 2A ,, . _
tai 5 3 sta
UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
NOTICE OF DOCKETING
2008-1314 - TAKEDA PHARMA V TEVA PHARMA
Date of docketing: 04/25/2008
Appeal from: United States District Court / District of Delaware
case no. 06-CV-33
Appellant(s): Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.
Critical dates include:
• Date of docketing. See Fed. Cir. R. 12.
• Entry of appearance. See Fed. Cir. R. 47.3.
• Certificate of interest. See Fed. Cir. R. 47.4.
• Docketing Statement. (Due within 14 days ofthe date ofdocketing, or within 30 days {the United
States or its ajjicer ar agency is a party in the appeal.) See the en banc order dated September 18,
2006. [Counsel can download a copy of the order and guidelines at www.cafc.uscourts. gov.]
• Requests for extensions of time. See Fed. Cir. R. 26 and 27. N.B. Delayed requests are not
favored by the court.
• Briefs. See Fed. Cir. R. 31. N.B. You will not receive a separate briefing schedule from the
CIerk's Office.
• Settlement discussions. See Fed. Cir. R. 33.
• Oral argument schedule conflicts. See Practice Note following Fed. Cir. R. 34.
Pro se parties should refer to the Guide for Pro Se Petitioners and Appellants.
Attachments:
• Official caption to all.
• Docketing Statement. (Only in cases where all parties are represented by counsel.)
• Rules of Practice to pro se parties. [Counsel can download the rules from www.cafc.uscou1ts. gov or
call 202.631%.6550.]
• Entry of appearance form to all.
• Infonnal brief form to pro se parties.
• Transcript Purchase Order form to appellants.
• Motion and Affidavit for Leave to Proceed in Forma Pauperis form to appellants owing the
docketing fee.
ns L.?
3
J an Horbaly E
Clerk `zg
N .,..,$€.!}_%_I
cc: US District Court, District of Delaware CO
Eric J. Lobenfeld -¤ EHQS
William F. Cavanaugh, Jr. 3
Jam L.No1th 77 A
Es?


Case 1 :06-cv-00033-SLR Document 189 Filed 04/28/2008 Page 2 of 2
UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
Official Captionl
2008-1314
TAKEDA PHARMACEUTICAL COMPANY LIMITED,
PIaintiff—AppelIee,
and
TAP PHARMACEUTICAL PRODUCTS, INC.,
PIaintiff—AppeIIee,
v.
TEVA PHARMACEUTICALS USA, INC.
and TEVA PHARMACEUTICAL INDUSTRIES LTD.,
Defendants—AppeIIants.
Appeal from the United States District Court for the District of Delaware in
case no. 06-CV-33, Judge Sue L. Robinson.
Authorized Abbreviated Captionz
TAKEDA PHARMA v TEVA PHARMA, 2008-1314
1 Required for use on petitions, formal briefs and appendices, court opinions, and court orders. FRAP l2(a); 32(a).
2 Authorized for use only on items not requiring the Official Caption as listed in note 1.